{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:02:45Z","timestamp":1768410165153,"version":"3.49.0"},"reference-count":22,"publisher":"Informa UK Limited","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1517\/14656566.6.15.2711","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T10:31:17Z","timestamp":1133346677000},"page":"2711-2718","source":"Crossref","is-referenced-by-count":14,"title":["Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review"],"prefix":"10.1517","volume":"6","author":[{"given":"Justin P","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,11,30]]},"reference":[{"key":"CIT0001","first-page":"2386","volume":"51","author":"PARKER WB","year":"1991","journal-title":"Cancer Res"},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1073\/pnas.89.7.2970","volume":"89","author":"CARSON DA","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"CIT0004","first-page":"3030","volume":"56","author":"XIE KC","year":"1996","journal-title":"Cancer Res"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0026-895X(24)12176-1","volume":"55","author":"PARKER WB","year":"1999","journal-title":"Mol. Pharmacol"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1182\/blood.V62.4.737.737","volume":"62","author":"CARSON DA","year":"1983","journal-title":"Blood"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood.V96.10.3537","volume":"96","author":"GENINI D","year":"2000","journal-title":"Blood"},{"key":"CIT0011","first-page":"2438","volume":"5","author":"LOTFI K","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(02)01484-3"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1021\/jm00080a029"},{"key":"CIT0014","first-page":"2719","volume":"36","author":"MARQUEZ VE","year":"1987","journal-title":"An acid stable purine nucleoside active against human immunodeficiency virus (HIV). Biochem. Pharmacol"},{"key":"CIT0015","first-page":"6335","volume":"9","author":"GANDHI V KANTARJIAN H, FADERL S et al.","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.031"},{"key":"CIT0018","first-page":"1309","volume":"44","author":"BONATE PL","year":"2004","journal-title":"GAYNON P et al.: Population pharmacokinetics of clofarabine, a second generation nucleoside analog, in pediatric patients with acute leukemia. J. Clin. Pharmacol."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1200\/JCO.1986.4.1.74","volume":"4","author":"WARRELL RP","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"CIT0020","first-page":"784","volume":"103","author":"JEHA S","year":"2004","journal-title":"CHAN KW et cll.: Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0925"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000090183"},{"key":"CIT0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00280-004-0906-y","volume":"55","author":"COOPER T","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200301000-00004"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808273390907"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.V96.5.1670","volume":"96","author":"ESTEY E","year":"2000","journal-title":"Blood"},{"key":"CIT0040","first-page":"1479","volume":"4","author":"STERNBERG A","year":"2003","journal-title":"Curr. Opin. Invest. Drugs"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.6.15.2711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:34:02Z","timestamp":1736123642000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.6.15.2711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,30]]},"references-count":22,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2005,11,30]]},"published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1517\/14656566.6.15.2711"],"URL":"https:\/\/doi.org\/10.1517\/14656566.6.15.2711","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,30]]}}}